Theragenics sets annual meeting date.ATLANTA--(BUSINESS WIRE)--March 12, 1996--Theragenics Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :THRX), the Atlanta based cancer treatment producer, today announced its Annual Meeting of Stockholders will be held Friday, May 24, 1996, at 10:00 a.m. Eastern Standard Time, at the Gwinnett Civic and Cultural Center, 6400 Sugarloaf Parkway, Duluth, GA 30136. The purpose of this meeting is to elect two directors (six directors constitute the entire board), to consider and vote on a proposal to ratify ratify v. to confirm and adopt the act of another even though it was not approved beforehand. Example: An employee for Holsinger's Hardware orders carpentry equipment from Phillips Screws and Nails although the employee was not authorized to buy anything. the appointment of independent public accountants, and to transact An earlier e-commerce system for the Web from Open Market that included order capture and secure order fulfillment using credit cards, ecash and other payment systems. It included customer service and subscription administration capabilities as well as an integrated database for reporting other business as may properly come before the meeting or any adjournments thereof. The Board of Directors has fixed the close of business on March 29, 1996, as the record date for the determination of the Stockholders entitled to notice of, and to vote at, the meeting. It is anticipated that the Proxy Statement Proxy Statement A document containing the information that a company is required by the SEC to provide to shareholders so they can make informed decisions about matters that will be brought up at an annual stockholder meeting. , Proxy and Annual Report will be mailed to stockholders entitled to notice of and to vote at the Annual Meeting on or about April 19, 1996. This announcement serves to satisfy the public disclosure requirement of the date of the Annual Meeting of Stockholders as addressed in the By-Laws of Theragenics Corporation. Theragenics Corporation, based in Norcross, GA, is the manufacturer TheraSeed(R), a rice-sized radioactive device used in the treatment of localized prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. with a one-time, minimally-invasive procedure. For additional information on the Company call Theragenics' Investor Relations Investor relations The process by which the corporation communicates with its investors. Department at 800/998-8479. The Company's common stock is traded on the NASDAQ stock exchange under the symbol THRX. CONTACT: Theragenics Corporation Ron Warren, Director of Investor Relations 800/998-THRX (8479) or 770/381-8338 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion